Sildenafil products contain a pharmacologically active drug substance together with inactive formulation components, or excipients. In many current U.S. products, the labeled drug substance is sildenafil citrate, while sildenafil is the active moiety responsible for PDE5 inhibition.
Product strength is generally expressed as the amount of sildenafil represented by the citrate salt. A tablet described as containing 50 mg of sildenafil therefore contains enough sildenafil citrate to provide the equivalent amount of sildenafil active moiety.
Inactive ingredients are much more product-specific. Viagra tablets, generic sildenafil tablets, Revatio suspension, Liqrev suspension, Revatio injection and Vybrique oral film all illustrate how products sharing sildenafil can have very different excipient systems.
A finished sildenafil medicine contains the active drug substance plus inactive ingredients required to manufacture, stabilize, coat, flavor, suspend, preserve or otherwise deliver the product in its intended dosage form.
For many U.S. sildenafil products, prescribing information lists sildenafil citrate as the active ingredient or drug substance. The pharmacologically relevant active moiety is sildenafil, and product strength is commonly expressed as an amount equivalent to sildenafil rather than as the total mass of the citrate salt.
The inactive portion differs substantially between products. A film-coated tablet can require binders, fillers, disintegrants and coating materials, whereas an oral suspension can require sweeteners, preservatives, viscosity modifiers and flavoring, and an injection can use a much simpler aqueous formulation.
| Ingredient Layer | Sildenafil Context |
|---|---|
| Active drug substance | Commonly sildenafil citrate |
| Active moiety | Sildenafil |
| Inactive ingredients | Product-specific excipients with formulation roles |
| Finished product | Combination of active drug substance, excipients and dosage-form design |
The terminology can be confusing because product labels use both sildenafil and sildenafil citrate. Sildenafil is the active moiety that inhibits PDE5, while sildenafil citrate is the citrate salt used as the active drug substance in many approved formulations.
For example, current VIAGRA labeling describes each tablet as containing sildenafil citrate equivalent to 25 mg, 50 mg or 100 mg of sildenafil. REVATIO similarly describes its 20 mg tablet strength as sildenafil citrate equivalent to 20 mg sildenafil.
This is why it is more precise to say that the medicine delivers sildenafil as the pharmacologically active moiety while commonly using sildenafil citrate as the pharmaceutical salt form. The distinction is chemical and formulation-related rather than evidence of two different therapeutic drugs.
| Term | Meaning |
|---|---|
| Sildenafil | Active moiety responsible for the primary PDE5 pharmacology |
| Sildenafil citrate | Citrate salt commonly used as the pharmaceutical drug substance |
| Equivalent to 50 mg sildenafil | Strength expressed as the amount of sildenafil active moiety supplied by the citrate salt |
| PDE5 inhibition | Pharmacological activity associated with sildenafil |
Sildenafil citrate is the salt formed from sildenafil and citrate. Salt formation is part of pharmaceutical drug-substance design and does not create a separate PDE5-inhibitor mechanism.
The mass of sildenafil citrate is greater than the mass of sildenafil represented by a labeled strength because the citrate portion contributes additional molecular mass. For that reason, labels commonly use wording such as 'sildenafil citrate equivalent to 50 mg sildenafil.'
The distinction should not be confused with inactive ingredients. Citrate is part of the active drug substance in sildenafil citrate, whereas fillers, coatings, flavors, preservatives and vehicles are separate formulation components. The chemistry and naming distinction is covered in more depth on the sildenafil citrate guide.
| Term | Description |
|---|---|
| Sildenafil | Active moiety |
| Sildenafil citrate | Salt form of the active drug substance |
| Labeled strength | Commonly expressed as equivalent amount of sildenafil |
| Inactive excipients | Separate formulation components not represented by the sildenafil strength |
Inactive ingredients, often called excipients, are components of the finished medicine that are not responsible for sildenafil's primary PDE5-inhibiting pharmacological effect. They nevertheless perform important pharmaceutical functions.
Solid tablets can contain diluents, binders, disintegrants, lubricants and film-coating materials. Oral suspensions can contain preservatives, sweeteners, flavors, buffering agents and viscosity modifiers. Oral films require a film-forming system, while injection uses excipients compatible with intravenous administration.
The word inactive therefore should not be interpreted as meaning irrelevant. Excipients can affect physical properties, appearance, taste, stability and administration, and the exact ingredient list can matter when a person needs to identify a known product-component hypersensitivity or intolerance.
| Inactive Ingredient Role | Possible Function |
|---|---|
| Diluent / filler | Provides suitable product mass and structure |
| Disintegrant | Helps a tablet break apart after administration |
| Coating component | Forms the external tablet layer |
| Sweetener / flavor | Improves palatability in liquid or film formulations |
| Preservative | Supports microbiological quality where applicable |
| Viscosity modifier | Helps maintain suspension properties |
| Vehicle | Provides the liquid phase of a suspension or injectable product |
Approved products do not need to use one universal excipient formula merely because they contain the same active drug. Different manufacturers can use different inactive ingredients within the regulatory requirements for their particular product.
This is visible among current sildenafil tablets. VIAGRA uses microcrystalline cellulose, anhydrous dibasic calcium phosphate, croscarmellose sodium, magnesium stearate and a coating system that includes hypromellose, titanium dioxide, lactose, triacetin and FD&C Blue No. 2 aluminum lake.
Current generic labels show variation. Some use colloidal silicon dioxide, polyethylene glycol, polyvinyl alcohol or talc; others use crospovidone or different coloring systems. The existence of an approved generic relationship therefore does not mean that the inactive ingredient list is identical to the reference product.
| Product Feature | Usually Shared or Variable? |
|---|---|
| Active moiety | Shared — sildenafil |
| Pharmaceutical salt | Commonly sildenafil citrate |
| Inactive ingredients | Can vary |
| Tablet coating system | Can vary |
| Coloring agents | Can vary |
| Manufacturer | Varies across approved products |
Current U.S. VIAGRA labeling describes sildenafil citrate as the active ingredient and the tablet strengths as equivalent to 25 mg, 50 mg or 100 mg sildenafil.
The listed inactive ingredients are microcrystalline cellulose, anhydrous dibasic calcium phosphate, croscarmellose sodium, magnesium stearate, hypromellose, titanium dioxide, lactose, triacetin and FD&C Blue No. 2 aluminum lake.
This list is useful as a concrete example of a branded sildenafil tablet formulation, but it should not be copied onto generic sildenafil products or other dosage forms. The relationship between the active drug and brand is covered on the sildenafil and Viagra page.
| VIAGRA Component | Current Label Context |
|---|---|
| Active drug substance | Sildenafil citrate |
| Active moiety | Sildenafil |
| Core tablet excipients | Microcrystalline cellulose, anhydrous dibasic calcium phosphate, croscarmellose sodium, magnesium stearate |
| Coating / additional components | Hypromellose, titanium dioxide, lactose, triacetin, FD&C Blue No. 2 aluminum lake |
REVATIO demonstrates especially clearly why there is no single sildenafil ingredient list: its tablet, powder-for-suspension and injectable formulations have different excipient systems.
REVATIO tablets contain sildenafil citrate plus anhydrous dibasic calcium phosphate, croscarmellose sodium, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, titanium dioxide and triacetin.
REVATIO powder for oral suspension uses citric acid, colloidal silicon dioxide, grape flavor, sodium benzoate, sodium citrate dihydrate, sorbitol, sucralose, titanium dioxide and xanthan gum. REVATIO injection is much simpler: each mL contains sildenafil citrate equivalent to 0.8 mg sildenafil, dextrose and water for injection.
| REVATIO Formulation | Ingredient Pattern |
|---|---|
| Tablet | Solid-tablet excipients including calcium phosphate, cellulose, croscarmellose, magnesium stearate and coating components |
| Powder for oral suspension | Citric acid, colloidal silica, grape flavor, sodium benzoate, sodium citrate, sorbitol, sucralose, titanium dioxide and xanthan gum |
| Injection | Sildenafil citrate, dextrose and water for injection |
Sildenafil tablets illustrate both ingredient consistency and manufacturer variation. The active drug is commonly supplied as sildenafil citrate, with the labeled tablet strength expressed as an equivalent amount of sildenafil.
Many tablet formulations use familiar pharmaceutical excipients such as microcrystalline cellulose, calcium phosphate, croscarmellose sodium, magnesium stearate, hypromellose and titanium dioxide. However, the exact combination is not universal.
For example, one current generic ED tablet label includes crospovidone and hydrophobic colloidal silica rather than reproducing the VIAGRA formula exactly, while another current generic product uses colloidal silicon dioxide, polyethylene glycol, polyvinyl alcohol and talc. The sildenafil tablets guide provides the broader tablet context.
| Tablet Ingredient Type | Examples Seen in Current Sildenafil Labels |
|---|---|
| Active drug substance | Sildenafil citrate |
| Fillers / structural excipients | Microcrystalline cellulose, dibasic calcium phosphate |
| Disintegrants | Croscarmellose sodium or crospovidone depending on product |
| Lubricants | Magnesium stearate or another product-specific lubricant |
| Coating materials | Hypromellose, titanium dioxide, triacetin or other product-specific systems |
| Coloring | Can include FD&C Blue No. 2 / indigo carmine systems in some products |
Sildenafil liquid formulations show why the specific product must be identified. REVATIO and several generic PAH products are supplied as powder for oral suspension and become a 10 mg/mL suspension only after reconstitution.
REVATIO's inactive ingredients include citric acid anhydrous, colloidal silicon dioxide, grape flavor, sodium benzoate, sodium citrate dihydrate, sorbitol, sucralose, titanium dioxide and xanthan gum.
LIQREV is a different presentation: it is supplied as a ready-to-use sildenafil oral suspension rather than powder requiring reconstitution. Its current label lists acesulfame potassium, citric acid monohydrate, glycerin, simethicone emulsion, sodium benzoate, sucralose, strawberry flavor, trisodium citrate dihydrate, xanthan gum and water as inactive ingredients. The sildenafil oral suspension guide explains the formulation differences.
| Liquid Product | Presentation | Selected Inactive Ingredients |
|---|---|---|
| REVATIO | Powder reconstituted to oral suspension | Sorbitol, grape flavor, sodium benzoate, sucralose, xanthan gum and related excipients |
| Generic REVATIO-type products | Powder for reconstitution | Generally similar functional categories but exact label remains product-specific |
| LIQREV | Ready-to-use oral suspension | Glycerin, acesulfame potassium, strawberry flavor, simethicone emulsion, sodium benzoate, sucralose, xanthan gum and water |
REVATIO injection has a much simpler composition than sildenafil tablets or flavored oral suspensions. It is supplied as a sterile ready-to-use intravenous solution.
Current labeling states that each mL contains 1.124 mg sildenafil citrate, equivalent to 0.8 mg sildenafil, together with 50.5 mg dextrose and water for injection.
The streamlined composition reflects the requirements of an intravenous formulation and should not be generalized to oral sildenafil products. The formulation and route context are covered on the sildenafil injection guide.
| Injection Component | Current REVATIO Context |
|---|---|
| Sildenafil citrate | 1.124 mg per mL |
| Equivalent sildenafil | 0.8 mg per mL |
| Dextrose | 50.5 mg per mL |
| Water for injection | Injection vehicle |
Ingredients and strength describe different dimensions of a sildenafil product. An ingredient list identifies what substances are present, whereas strength identifies the amount of active sildenafil represented in a dosage unit or concentration.
Because many products use sildenafil citrate, the labeled sildenafil strength is not the total mass of the citrate salt. VIAGRA tablets, for example, contain enough sildenafil citrate to provide the equivalent of 25 mg, 50 mg or 100 mg sildenafil.
Liquid products express strength as concentration, such as 10 mg/mL sildenafil after REVATIO suspension is reconstituted or in the finished LIQREV suspension. These values should not be confused with the amounts of sweeteners, preservatives, vehicles or other inactive ingredients.
| Concept | Meaning |
|---|---|
| Ingredient list | All active and inactive components in the finished formulation |
| Tablet strength | Amount of sildenafil represented in one tablet or film |
| Liquid concentration | Amount of sildenafil represented per unit volume |
| Sildenafil citrate mass | Greater than the equivalent sildenafil active-moiety mass |
| Inactive ingredient amount | Separate from labeled sildenafil strength |
An ingredient is an individual substance present in the medicine, while formulation describes how active and inactive ingredients are combined into the complete pharmaceutical product.
This is why different dosage forms containing sildenafil require very different ingredient systems. A compressed film-coated tablet, a dissolving oral film, a suspension and an intravenous solution each need excipients suited to their physical and administration requirements.
Current VYBRIQUE oral film demonstrates this clearly. Its inactive ingredients include Blue Videojet ink, FD&C Blue No. 2, glycerin, grapefruit flavor, lemon flavor, maltodextrin, polysorbate 20, polyvinyl acetate dispersion, propylene glycol monocaprylate, sucralose and titanium dioxide — a composition very different from conventional sildenafil tablets. The broader dosage-form map is available on the sildenafil formulations page.
| Dosage Form | Typical Ingredient-System Needs |
|---|---|
| Tablet | Fillers, disintegrants, lubricants and coating materials |
| Oral film | Film-forming, plasticizing, flavoring and appearance components |
| Oral suspension | Liquid vehicle, sweeteners, preservatives, flavoring and suspension stabilizers |
| Injection | Sterile aqueous formulation components compatible with intravenous administration |
Ingredient information can matter for reasons beyond identifying the active drug. A person with a known hypersensitivity to a product component needs the ingredient list for the exact formulation being used rather than a generic list taken from another sildenafil product.
Ingredient lists can also answer narrower formulation questions. VIAGRA and current REVATIO tablets contain lactose-related ingredients, REVATIO suspension contains sorbitol and grape flavor, LIQREV contains a different sweetener and flavor system, and VYBRIQUE contains lemon and grapefruit flavors and several film-forming excipients.
Product-specific statements can also differ. For example, current VYBRIQUE labeling specifically states that the oral film contains no ingredient made from a gluten-containing grain. Such a statement should not be generalized automatically to every sildenafil product.
| Ingredient Question | Why the Exact Product Matters |
|---|---|
| Known component hypersensitivity | Different products can contain different excipients |
| Lactose | Present in some sildenafil tablet formulations but not universally |
| Sorbitol | Present in REVATIO-type suspension formulations |
| Flavor systems | Differ between grape-flavored REVATIO suspension, strawberry-flavored LIQREV and flavored oral film |
| Coloring / coating agents | Can differ between tablet and oral-film products |
| Gluten-related product statement | Current VYBRIQUE label contains a specific no-gluten-grain ingredient statement |
There is no universal inactive-ingredient list for sildenafil because sildenafil is an active drug used in multiple finished products from multiple manufacturers and across several dosage forms.
Even products that appear similar can differ. Two approved generic tablets can use different binders, disintegrants, lubricants, coloring agents or coating systems while delivering the same sildenafil active moiety within their respective regulatory framework.
Differences become much larger across dosage forms: VIAGRA tablet, VYBRIQUE oral film, REVATIO suspension, LIQREV suspension and REVATIO injection have visibly different pharmaceutical compositions. The exact current label for the dispensed product is therefore the authoritative source.
| Factor | Effect on Ingredient List |
|---|---|
| Brand | Can identify a distinct formulation |
| Manufacturer | Can change excipient selection |
| Dosage form | Requires a different pharmaceutical design |
| Route | Changes formulation requirements |
| Product generation | Newer formulations such as oral film can introduce entirely different excipient systems |
| Current product label | Defines the ingredient list for the specific medicine |
Sildenafil is the pharmacologically active moiety. Many current U.S. products use sildenafil citrate as the active drug substance, with strength expressed as the equivalent amount of sildenafil.
No. Sildenafil citrate is the citrate salt of sildenafil. The sildenafil portion is the active moiety responsible for the primary PDE5 pharmacology.
Current U.S. VIAGRA labeling lists microcrystalline cellulose, anhydrous dibasic calcium phosphate, croscarmellose sodium, magnesium stearate, hypromellose, titanium dioxide, lactose, triacetin and FD&C Blue No. 2 aluminum lake.
Not necessarily. Approved generic tablets share the relevant active drug but can use different excipients, coating systems and coloring ingredients. The current label for the specific manufacturer should be checked.
No. Both provide sildenafil in a 10 mg/mL oral-suspension context, but REVATIO is supplied as powder for reconstitution with a grape-flavored excipient system, while LIQREV is supplied as a ready-to-use suspension with a different formulation that includes glycerin, strawberry flavor and other product-specific ingredients.
Use the current official product labeling for the exact brand, manufacturer and dosage form. A formulation-specific label is more reliable than a generic sildenafil ingredient list because inactive components can differ substantially.